![Compliances under Drugs Rules, 1945 [Part IV]](https://1-comply.com/wp-content/uploads/2026/01/ChatGPT-Image-Jan-21-2026-03_40_50-PM-768x512.png)
Background
The Drugs Rules, 1945 were introduced under the Drugs and Cosmetics Act to standardize how medicines are manufactured, tested, and sold across India. They emerged during a period when the government sought stronger safeguards against unsafe or ineffective pharmaceuticals. The rules laid out scientific criteria for quality, labeling, storage, and distribution of medicinal products. By bringing regulatory clarity, they helped protect public health and support the growth of a structured pharmaceutical sector. Over time, amendments have kept the framework relevant as medical science and industry standards evolved.
Applicability
These Rules apply to:
Compliance Requirements under the Rules
Form 41 is the Registration Certificate issued by CDSCO to certify manufacturing entity or importing entity that the products intended for manufacture or import met baseline standards for safety and efficacy. Each factory / unit requires a separate Registration Certificate.
A single application may be made, and a single Registration Certificate in Form 41 may be issued in respect of the import of more than one drug or class of drugs, manufactured by the same manufacturer. Provided that the drug or classes of drugs, are manufactured at one factory or more than one factory functioning conjointly as a single manufacturing unit. Provided further that if a single manufacturer has two or more factories situated in different places manufacturing the same or different drugs, separate Registration Certificates shall be required in respect of the drugs manufactured by each such factory.
Renewal Period: Valid for a period of three years from the date of its issue. Provided that if application for a fresh registration certificate is made 9 months before the expiry of the existing certificate the current certificate shall be deemed to continue in force until orders are passed on the application.
An import licence in Form 10 is required for the import of drugs, except for those listed in Schedule X. An application for an import licence must be submitted to the licensing authority in Form 8 for drugs excluding those listed in Schedule X.
Application for an import licence must be submitted to the licensing authority in Form 8 for drugs excluding those listed in Schedule X. Every application in Form 8 or Form 8A must include a copy of the Registration Certificate issued in Form 41 under rule 27A.
Renewal Period: Valid for a period of three years from the date of its issue. Provided that if application for a fresh licence is made three months before the expiry of the existing licence the current licence shall be deemed to continue in force until orders are passed on the application.
An import licence in Form 10A is required for the import of drugs, except for those listed in Schedule X. An application for an import licence must be submitted to the licensing authority in Form 8A for drugs excluding those listed in Schedule X.
Application for an import licence must be submitted to the licensing authority in Form 8A for drugs excluding those listed in Schedule X. Every application in Form 8 or Form 8A must include a copy of the Registration Certificate issued in Form 41 under rule 27A.
Renewal Period: Valid for a period of three years from the date of its issue. Provided that if application for a fresh licence is made three months before the expiry of the existing licence the current licence shall be deemed to continue in force until orders are passed on the application.
A person aggrieved by the order for suspension or cancellation of registration certificate may appeal to the Central Government within 30 days of receipt of the order.
A person aggrieved by the order for suspension or cancellation of registration certificate may appeal to the Central Government within 30 days of receipt of the order.
No biological or other special product specified in Schedule C or C(l) shall be imported after the date shown on the label, wrapper or container of the drug as the date up to which the drug may be expected to retain a potency not less than, or not to acquire a toxicity greater than, that required, or as the case may be, permitted by the prescribed test.
No drug, the manufacture, sale or distribution of which is prohibited in the country of origin, shall be imported under the same name or under any other name except for the purpose of examination, test or analysis
This provision states that imported drugs must meet prescribed standards of strength, quality, and purity. If specific standards are provided in the rules, the drug must comply with them. Additionally, the licensing authority will not permit the import of any drug if it has less than 60% of its shelf life remaining at the time of import
No drug shall be imported unless it is packed and labelled in conformity with the rules in Parts IX and X and conforms the standards laid down in Part XII provided that in the case of drugs intended for veterinary use, the packing and labelling shall conform the rules in Parts IX and X and Sch F(l).
No Homoeopathic medicine shall be imported unless it is packed and labelled in conformity with the rules in Part IXA
Small quantities of drugs the import of which is otherwise prohibited under section 10 of the Act may be imported for the purpose of examination, test or analysis subject to the some conditions as prescribed in Rule 33. The application for such licence shall be made in Form 12.
Under Section 10 of the Act, small quantities of otherwise prohibited drugs may be imported for examination, testing, or analysis, subject to the following conditions:
A person aggrieved by the order for cancellation of licence for examination, test or analysis may appeal to the Central Government within 3 months of the date of the order.
Patent or proprietary medicine shall be imported in containers intended for retail sale
Patent or proprietary medicine may be imported in bulk containers by any person who holds a licence to manufacture, if such person has obtained permission in writing to import such medicines from the licensing authority at least three months prior to the date of import and the imports are made within a period of twelve months from the date of issue of such permission.
All consignments of drugs sought to be imported shall be accompanied by an invoice or other statement showing the name and address of the manufacturer and the names and quantities of the drugs.
Penalty & Punishment
a. Cancellation of license to import or manufacture
b. Criminal prosecution due to offenses such as unauthorized manufacturing, import or distribution of drugs leading to imprisonment of responsible persons
c. Monetary fines, the quantum of which may vary depending on the severity of the offense.
Disclaimer: The information contained in this Article is intended solely for personal non-commercial use of the user who accepts full responsibility of its use. The information in the article is general in nature and should not be considered to be legal, tax, accounting, consulting or any other professional advice. We make no representation or warranty of any kind, express or implied regarding the accuracy, adequacy, reliability or completeness of any information on our page/article.